As of 1 January 2027, Novo Nordisk will lower the list price, or wholesale acquisition cost, to $675 for Wegovy (semaglutide) ...

Incyte Biosciences UK has received NICE approval for eligible NHS patients with non-segmental vitiligo to be reimbursed for Opzelura (ruxolitinib) cream 15mg/g. This comes after more than two years of ...

Proud to be ranked 3rd among the Top 10 UK-focused agencies, along with other categories, Grace Communications finds inspiration in being included in PMLive’s Top 40 Creative Healthcare Agencies 2025.

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve ...

The board will support the CGT Catapult in identifying and removing barriers to the widespread adoption of advanced therapies ...

“The UK Singapore Chamber Trade Accelerator is a great initiative to help fast-track world-class UK innovation into one of ...

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and ...

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver ...

The Pharmaceutical Marketing Society (PM Society) has announced the launch of Pharmony, a new industry-wide initiative ...

Rare diseases are defined as conditions affecting fewer than 200,000 people in the US or fewer than five in 10,000 individuals in the European Union ...

Human Continuum has announced the appointment of Dr Omar Khalid Sial as Chief Scientific Officer (CSO).

While a lack of meal announcements can lead to lower glycaemic control, it reduces the mental burden for those with type 1 diabetes ...